Madrigal Pharmaceuticals, Inc. (MDGL)
435.01
-1.86
(-0.43%)
USD |
NASDAQ |
Feb 20, 16:00
435.20
+0.19
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals Shareholders Equity (Quarterly) : 602.69M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Eli Lilly & Co. | 26.54B |
| Insmed, Inc. | 738.98M |
| Johnson & Johnson | 81.54B |
| Crinetics Pharmaceuticals, Inc. | 1.072B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.260B |
| Total Liabilities (Quarterly) | 656.90M |
| Debt to Equity Ratio | 0.5768 |
| Current Ratio | 4.015 |
| Net Debt Paydown Yield | -0.35% |